Effectiveness of First‐Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA

BACKGROUND. Scant real‐world data exist on the clinical outcomes associated with the use of bevacizumab‐containing chemotherapy (B+CT) in patients with metastatic colorectal cancer (mCRC). The primary objective of the GRETA cohort study was to compare the overall survival (OS) of patients with mCRC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Franchi, Matteo, Barni, Sandro, Tagliabue, Giovanna, Ricci, Paolo, Mazzucco, Walter, Tumino, Rosario, Caputo, Antonietta, Corrao, Giovanni
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Health Outcomes and Economics of Cancer Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519764/
https://ncbi.nlm.nih.gov/pubmed/30097524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0314
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados